Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 5 November 1976:
Vol. 194. no. 4265, pp. 632 - 635
DOI: 10.1126/science.185695
Prev | Table of Contents | Next

Articles

Science, Vol 194, Issue 4265, 632-635
Copyright © 1976 by American Association for the Advancement of Science

articles

The C-fragment of beta-lipotropin: an endogenous neuroleptic or antipsychotogen?

YF Jacquet and N Marks

Microinjection of the C-fragment (also called beta-endorphin), which is amino acid sequence 61-91 of the endogenous pituitary hormone, beta-lipotropin (beta-LPH), in the periaqueductal gray of the rat resulted in profound sedation and catalepsy, while microinjection of smaller fragments-that is, methionine-enkephalin [sequence beta-LPH-(61-65)] and its related pentapeptide, leucine enkephalin, and alpha-endorphin [sequence beta-LPH-(61-76)] resulted in attenuated forms of this behavior. This indicates that the C-fragment is an important neuromodulator of the central nervous system. The similarity of this behavior to that seen after systemic administration to experimental animals of exogenous neuroleptics suggests that a disturbance in the bioavailability of this neuropeptide to receptor sites in brain-perhaps due to lack of enzymatic cleavage from the circulating parent hormone, beta-lipotropin--may be an etiological factor in those psychopathological states for which the exogenous neuroleptics exert an ameliorative influence.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Peptide-dopamine interactions in the central nervous system: implications for neuropsychiatric disorders.
A.J. Stoessl (1989)
J Psychopharmacol 3, 99-120
   PDF »
Postural asymmetry and movement disorder after unilateral microinjection of adrenocorticotropin 1-24 in rat brainstem.
Y. Jacquet and G. Abrams (1982)
Science 218, 175-177
   Abstract »    PDF »
Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone.
Y Hosobuchi, D. Baskin, and S. Woo (1982)
Science 215, 69-71
   PDF »
{beta}-Endorphin and Schizophrenia.
P. A. Berger, S. J. Watson, H. Akil, G. R. Elliott, R. T. Rubin, A. Pfefferbaum, K. L. Davis, J. D. Barchas, and C. H. Li (1980)
Arch Gen Psychiatry 37, 635-640
   Abstract »    PDF »
{beta}-Endorphin: Intravenous Infusion Causes Behavioral Change in Psychiatric Inpatients.
R. H. Gerner, D. H. Catlin, D. A. Gorelick, K. K. Hui, and C. H. Li (1980)
Arch Gen Psychiatry 37, 642-647
   Abstract »    PDF »
Specific nonopiate receptors for beta-endorphin.
E Hazum, K. Chang, and P Cuatrecasas (1979)
Science 205, 1033-1035
   Abstract »    PDF »
Basic and Clinical Studies of Endorphins.
W. E. BUNNEY Jr., C. B. PERT, W. KLEE, E. COSTA, A. PERT, and G. C. DAVIS (1979)
Ann Intern Med 91, 239-250
   Abstract »    PDF »
Pituitary hormones in brain: where, how, and why?.
D. Krieger and A. Liotta (1979)
Science 205, 366-372
   Abstract »    PDF »
Improvement of Schizophrenic Patients Treated With Des-Tyr1]-{gamma}-endorphin (DT{gamma}E).
W. M. A. Verhoeven, H. M. van Praag, J. M. van Ree, and D. de Wied (1979)
Arch Gen Psychiatry 36, 294-298
   Abstract »    PDF »
Effect of an Opiate Antagonist on Movement Disorders.
J. G. Nutt, A. J. Rosin, T. Eisler, D. B. Calne, and T. N. Chase (1978)
Arch Neurol 35, 810-811
   Abstract »    PDF »
beta-Endorphin is not detectable in plasma from normal human subjects.
T Suda, A. Liotta, and D. Krieger (1978)
Science 202, 221-223
   Abstract »    PDF »
Opiate effects after adrenocorticotropin or beta-endorphin injection in the periaqueductal gray matter of rats.
Y. Jacquet (1978)
Science 201, 1032-1034
   Abstract »    PDF »
Effects of naloxone on schizophrenia: reduction in hallucinations in a subpopulation of subjects.
S. Watson, P. Berger, H Akil, M. Mills, and J. Barchas (1978)
Science 201, 73-76
   Abstract »    PDF »
Endorphins in Psychiatry: An Overview and a Hypothesis.
K. Verebey, J. Volavka, and D. Clouet (1978)
Arch Gen Psychiatry 35, 877-888
   Abstract »    PDF »
Different brain areas mediate the analgesic and epileptic properties of enkephalin.
H Frenk, B. McCarty, and J. Liebeskind (1978)
Science 200, 335-337
   Abstract »    PDF »
Opiate peptide modulation of amino acid responses suggests novel form of neuronal communication.
J. Barker, J. Neale, T. Smith Jr, and R. Macdonald (1978)
Science 199, 1451-1453
   Abstract »    PDF »
Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors?.
Y. Jacquet, W. Klee, K. Rice, I Iijima, and J Minamikawa (1977)
Science 198, 842-845
   Abstract »    PDF »
beta-Endorphin: endogenous opiate or neuroleptic?.
D. Segal, R. Browne, F Bloom, N Ling, and R Guillemin (1977)
Science 198, 411-414
   Abstract »    PDF »
beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.
R Guillemin, T Vargo, J Rossier, S Minick, N Ling, C Rivier, W Vale, and F Bloom (1977)
Science 197, 1367-1369
   Abstract »    PDF »
Intravenous naloxone administration in schizophrenia and affective illness.
G. Davis, W. Bunney Jr, E. DeFraites, J. Kleinman, D. van Kammen, R. Post, and R. Wyatt (1977)
Science 197, 74-77
   Abstract »    PDF »
Morphine and enkephalin: analgesic and epileptic properties.
G Urca, H Frenk, J. Liebeskind, and A. Taylor (1977)
Science 197, 83-86
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)